Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.
Public ClinicalTrials.gov record NCT04380688. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of Acalabrutinib With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19
Study identification
- NCT ID
- NCT04380688
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 62 participants
Conditions and interventions
Conditions
Interventions
- Acalabrutinib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 130 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 12, 2020
- Primary completion
- Nov 15, 2020
- Completion
- Nov 15, 2020
- Last update posted
- Sep 12, 2021
2020
United States locations
- U.S. sites
- 31
- U.S. states
- 15
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Anniston | Alabama | 36207 | — |
| Research Site | Mobile | Alabama | 36604 | — |
| Research Site | Escondido | California | 92029 | — |
| Research Site | Fullerton | California | 92835 | — |
| Research Site | Glendale | California | 91206 | — |
| Research Site | Newport Beach | California | 92663 | — |
| Research Site | New Haven | Connecticut | 06519 | — |
| Research Site | Washington D.C. | District of Columbia | 20010 | — |
| Research Site | Fort Lauderdale | Florida | 33308 | — |
| Research Site | Jacksonville | Florida | 32207 | — |
| Research Site | Jacksonville | Florida | 32209 | — |
| Research Site | Loxahatchee Groves | Florida | 33470 | — |
| Research Site | Fort Wayne | Indiana | 46804 | — |
| Research Site | Louisville | Kentucky | 40207 | — |
| Research Site | Annapolis | Maryland | 21401 | — |
| Research Site | Baltimore | Maryland | 21287 | — |
| Research Site | Bethesda | Maryland | 20889 | — |
| Research Site | Bethesda | Maryland | 20892-1374 | — |
| Research Site | Silver Spring | Maryland | 20910 | — |
| Research Site | Hackensack | New Jersey | 07601 | — |
| Research Site | Albany | New York | 12208 | — |
| Research Site | Buffalo | New York | 14263 | — |
| Research Site | New York | New York | 10029 | — |
| Research Site | The Bronx | New York | 10467 | — |
| Research Site | Philadelphia | Pennsylvania | 19140 | — |
| Research Site | Nashville | Tennessee | 38120 | — |
| Research Site | Houston | Texas | 77030 | — |
| Research Site | Houston | Texas | 77090 | — |
| Research Site | Tyler | Texas | 75701 | — |
| Research Site | Richmond | Virginia | 23298 | — |
| Research Site | Renton | Washington | 98055 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04380688, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 12, 2021 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04380688 live on ClinicalTrials.gov.